Utah Medical Products (UTMD) Financials

$74.75

$-0.26 (-0.35%)

As on 24-Sep-2026 15:28EDT

Market cap

$235 Mln

Revenue (TTM)

$36 Mln

P/E Ratio

22.5

P/B Ratio

1.9

Div. Yield

1.7 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	36.11	38.52	40.90	50.22	52.28	49.05
Cost of Revenue	16.29	18.65	16.76	20.19	20.09	18.14
Gross Profit	19.82	19.88	24.14	30.04	32.20	30.92
Operating Expenses	9.54	8.47	10.55	13.26	12.41	12.04
Operating Profit (EBIT)	10.28	11.40	13.59	16.78	19.79	18.88
Other Income	--	--	--	--	0.21	0.02
Profit before Tax	12.88	14.11	16.80	20.09	20.66	19.06
Provision for Tax	2.40	2.82	2.93	3.45	4.19	4.27
Profit after Tax (Net Income)	10.49	11.29	13.87	16.64	16.47	14.79
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	16.47	14.79

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	122.03	119.27	117.43	128.31	114.25	107.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.47	0.68	1.35	2.44	3.66	4.75
Current Liabilities	2.07	2.60	3.76	4.71	5.96	3.75
Total Liabilities	126.64	122.54	122.54	135.46	123.87	115.64

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	23.93	24.80	26.21	29.19	33.96	42.48
Current Assets	100.64	97.74	96.33	106.27	89.92	73.16
Total Assets	126.64	122.54	122.54	135.46	123.87	115.64
Total Debt*	0.20	0.23	0.34	0.30	0.34	0.40
Net Current Assets	98.57	95.14	92.57	101.56	84.17	69.56

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	14.69	14.83	22.28	21.15	21.20
Cash Flow from Investing Activities	--	-0.37	-0.21	-0.64	-0.82	-0.55
Cash from Financing Activities	--	-12.34	-23.84	-4.17	-5.48	-10.91
Net Cash Inflow / Outflow	--	--	--	--	14.85	9.38

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	3.28	3.53	4.10	4.58	4.53	4.03
Cash EPS ($)	--	4.47	4.94	6.53	6.48	6.02
Adjusted Book Value ($)	--	37.29	34.66	35.36	31.43	29.22
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.59	4.38	6.14	5.82	5.78
Free Cash Flow per Share ($)	--	4.48	4.31	5.96	5.59	5.63

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	9.51	11.26	13.68	14.83	14.04
ROE (%)	8.69	9.54	11.29	13.72	14.88	14.09
ROA (%)	8.40	9.21	10.76	12.83	13.76	13.01
EBIT Margin (%)	33.94	36.63	41.08	36.60	39.52	38.86
Net Margin (%)	29.04	29.30	33.92	33.12	31.38	30.14
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-7.00	-0.06	-0.19	-0.04	0.07	0.16
EBIT Growth (%)	-16.92	-16.02	-8.61	-11.01	8.38	39.05
Net Profit Growth (%)	-16.47	-18.65	-16.60	0.98	11.39	36.95
EPS Growth (%)	-12.17	-0.14	-0.11	0.01	0.12	0.36
Book Value Growth (%)	5.86	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	22.55	15.86	15.01	18.37	22.18	24.80
Price / Book Value	1.93	1.50	1.77	2.38	3.20	3.42
Dividend Yield (%)	1.66	--	--	--	--	--
EV/EBITDA	11.68	5.48	6.42	1.10	10.48	11.62
Close Price ($)	68.98	55.96	61.47	84.22	100.53	100.00
High Price ($)	75.75	65.56	85.76	102.40	109.50	133.87
Low Price ($)	53.66	51.26	60.39	75.00	80.10	81.01
Market Cap ($ Cr)	235.48	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	--	0.00	0.00	0.00	0.00
Current Ratio	48.62	37.62	25.64	22.56	15.09	19.53
Quick Ratio	44.27	34.57	23.29	20.53	13.61	17.77
Interest Coverage	--	--	--	--	23.77	4.56

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	9.87	9.14	10.01	6.75	10.59	10.46
Asset Turnover	0.29	0.31	0.32	0.39	0.44	0.43
Receivable days	--	36.11	33.41	32.46	37.27	34.38
Inventory Days	--	164.03	200.43	166.43	140.12	129.07
Payable days	--	14.24	14.30	17.98	17.99	15.60
Cash Conversion Cycle	--	185.90	219.55	180.92	159.39	147.85

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.